To validate the clinical relevance of RNase1 in patients with HCC, we performed a tissue microarray-based immunohistochemical study of RNase1 expression in 174 HCC samples (Supplementary Table 3). The gene discussed is RNASE1; the disease is hepatocellular carcinoma.